Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Breast Cancer Research : BCR|July 16, 2026
Three ct-miRNA signature predicts disease outcome in early breast cancer womenGiulia Cosentino, Mara Lecchi, Marta Giussani, et al.
Scientific Reports|August 18, 2018
Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancerSandra L Romero-Cordoba, Sergio Rodriguez-Cuevas, Veronica Bautista-Pina, et al.
Oncotarget|July 3, 2018
MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumabAlessandra Cataldo, Claudia Piovan, Ilaria Plantamura, et al.
Cancer Research|September 19, 2007
MicroRNA signatures in human ovarian cancerMarilena V Iorio, Rosa Visone, Gianpiero Di Leva, et al.
Molecular Oncology|May 15, 2012
Oncosuppressive role of p53-induced miR-205 in triple negative breast cancerClaudia Piovan, Dario Palmieri, Gianpiero Di Leva, et al.
Nucleic Acids Research|October 24, 2008
UCbase & miRfunc: a database of ultraconserved sequences and microRNA functionCristian Taccioli, Enrica Fabbri, Rosa Visone, et al.
International Journal of Cancer|March 21, 2014
Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomasRoberta Zappasodi, Alessandra Cavanè, Marilena V Iorio, et al.
Journal of the National Cancer Institute|April 15, 2010
MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancerGianpiero Di Leva, Pierluigi Gasparini, Claudia Piovan, et al.
Cancer Research|July 13, 2016
miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast CancerElvira D'Ippolito, Ilaria Plantamura, Lucia Bongiovanni, et al.
Pageof 6